Noa Shoshani

Suggest Changes
Learn More
PURPOSE Adoptive cell transfer (ACT) using autologous tumor-infiltrating lymphocytes (TIL) was reported to yield objective responses in about 50% of metastatic patients with melanoma. Here, we(More)
  • 1